A Perfect Beta-Blocker for Kidney: Sglt-2 Inhibitor

J Assoc Physicians India. 2021 Jul;69(7):11-12.
No abstract available

MeSH terms

  • Canagliflozin
  • Diabetes Mellitus, Type 2* / drug therapy
  • Humans
  • Hypoglycemic Agents
  • Kidney
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Canagliflozin